Results 71 to 80 of about 18,601 (174)

Efficacy of Anakinra for Various Types of Crystal-Induced Arthritis in Complex Hospitalized Patients: A Case Series and Review of the Literature

Mediators of Inflammation, 2015
Background. There are few data on anakinra use after failure of conventional medications for crystal-induced peripheral arthritis and/or crowned dens syndrome among complex hospitalized patients. Methods.
A. Aouba, S. Deshayes, L. Frenzel, A. Decottignies, C. Pressiat, B. Bienvenu, F. Boue, G. Damaj, O. Hermine, S. Georgin-Lavialle   +9 more
doaj   +1 more source

Preserving Valued Activities in Life for Adults With Rheumatoid Arthritis: Development and Pre‐Testing Refinement of the PREVAIL Model of Care

ACR Open Rheumatology, Volume 8, Issue 8, August 2026.
Objective Rehabilitation is rarely integrated into routine rheumatology care, despite high rates of functional limitation in adults with rheumatoid arthritis (RA). The Preserving Valued Activities in Life (PREVAIL) model of care proposes a function‐focused screening survey administered during routine rheumatology visits to guide referrals to ...
Louise M. Thoma, Joel R. Thompson, Jason Sharpe, Beth Jonas, Patti Katz, Kelli Allen   +5 more
wiley   +1 more source

Interleukin 1 inhibition with anakinra in adult-onset Still disease: a meta-analysis of its efficacy and safety

Drug Design, Development and Therapy, 2014
Dongsheng Hong,1 Zhihai Yang,1 Shuyin Han,1 Xingguang Liang,1 Kuifen Ma,1 Xingguo Zhang1,2 1Department of Pharmacy, the First Affiliated Hospital of College of Medicine, Zhejiang University, 2College of Pharmaceutical Science, Zhejiang Chinese Medical ...
Hong D, Yang Z, Han SY, Liang X, Ma K, Zhang X   +5 more
doaj  

Targeted Anti‐IL‐1 Immunomodulatory Therapy in Pediatric Onset PPP1R13L‐Related Arrhythmogenic Cardiomyopathy

American Journal of Medical Genetics Part A, Volume 200, Issue 8, Page 1807-1813, August 2026.
ABSTRACT Autosomal recessive loss‐of‐function variants in PPP1R13L cause an ultra‐rare cardiocutaneous syndrome characterized by rapidly progressive arrhythmogenic cardiomyopathy (ACM). PPP1R13L encodes iASPP, which has two potentially overlapping mechanisms driving ACM as both a regulator of NFκB‐mediated inflammation and a binding partner within the ...
Aaron Renberg, Savannah Coppersmith, Owen Merritt, Amer Heider, Adam Helms, Thomas Michniacki, Jack Luxford, Sarah Josephi‐Taylor, Philip Roberts, Joshua Meisner   +9 more
wiley   +1 more source

Refractory Relapsing–Remitting Adult‐Onset Still's Disease in an Adolescent Female: A Rare Case Report

Clinical Case Reports, Volume 14, Issue 8, August 2026.
ABSTRACT Adult‐onset Still's disease (AOSD) is a rare systemic autoinflammatory condition that presents with symptoms such as episodic fevers, a transient rash, inflammatory arthritis, and significant systemic inflammation. Diseases that have a relapsing–remitting clinical course can be challenging to diagnose and treat. We present a case of an 18 year
Tasnim Nafian, Mohd. Mujtaba Akib Bhuiyan, Kazi Ali Aftab, Khaled Mahbub Murshed, Md. Abul Kalam Azad   +4 more
wiley   +1 more source

Aseptic meningitis due to intravenous immunoglobulin therapy (IVIG) in therapy‐refractory pyoderma gangraenosum

JDDG: Journal der Deutschen Dermatologischen Gesellschaft, EarlyView.
Katharina A. Kälber, Knut Schäkel, Alexander Enk, Julia K. Winkler   +3 more
wiley   +1 more source

Glofitamab in Heavily Pretreated Mantle Cell Lymphoma Patients: A Multicenter Real‐World Case Series

eJHaem, Volume 7, Issue 4, August 2026.
ABSTRACT Background Relapsed or refractory mantle cell lymphoma (r/r MCL) remains difficult to treat despite therapeutic advances. Methods This multicenter retrospective study included 10 patients with r/r MCL treated with glofitamab across five sites in Austria and Italy before European approval (January 2023–May 2024).
Natalia Rotter, Markus Raderer, Agnes List, Ferdinand Haslbauer, Olga Saini, Alexander Egle, Teresa Magnes, Michael Leisch, Emine Kaynak, Veronika Buxhofer‐Ausch, Beatrice Casadei, Felix Keil, Holger Rumpold, Georg Hess, Richard Greil, Pier Luigi Zinzani, Thomas Melchardt   +16 more
wiley   +1 more source

Recognizing Hemophagocytic Lymphohistiocytosis (HLH) in an Urban Population: Clinical Characteristics, Treatment Patterns, and Outcomes

eJHaem, Volume 7, Issue 4, August 2026.
ABSTRACT Introduction Hemophagocytic lymphohistiocytosis (HLH) is a life‐threatening hyperinflammatory syndrome with high mortality in adults. Diagnosis remains challenging due to nonspecific clinical features and overlap with sepsis, malignancy, and other inflammatory conditions. Data on HLH in underserved populations are limited. Methods We performed
Safia Ansari, Kristy Bono, Merry Zhai, Aishwarya Subash, Ankit Shah, Joshua Kra   +5 more
wiley   +1 more source

Improved survival outcomes with anakinra over etoposide-based therapies for the management of adults with hemophagocytic lymphohistiocytosis: a retrospective multicenter research network study

Therapeutic Advances in Hematology
Background: Hemophagocytic lymphohistiocytosis (HLH) is a rare life-threatening, hyperinflammatory syndrome for which etoposide-based regimens have historically been the standard of care.
Benjamin J. Lee
doaj   +1 more source

Advances in Pharmacological Therapy of Benign Tracheal Stenosis: A Meta‐Analysis of Preclinical Studies

Laryngoscope Investigative Otolaryngology, Volume 11, Issue 4, August 2026.
ABSTRACT Background Benign tracheal stenosis, characterized by granulation hyperplasia, is a rare and serious disease threatening human health. Interventional bronchoscopy demonstrates limited therapeutic efficacy and poses a risk of re‐injury to the airway.
Dengyuan Li, Jie Zeng, Rufang Li, Rong Wang, Danxiong Sun   +4 more
wiley   +1 more source